SU432703A3 - - Google Patents
Info
- Publication number
- SU432703A3 SU432703A3 SU1820018A SU1820018A SU432703A3 SU 432703 A3 SU432703 A3 SU 432703A3 SU 1820018 A SU1820018 A SU 1820018A SU 1820018 A SU1820018 A SU 1820018A SU 432703 A3 SU432703 A3 SU 432703A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- carbon atoms
- gelatin
- dicarbomethoxy
- dihydropyridine
- titanium dioxide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S206/00—Special receptacle or package
- Y10S206/828—Medicinal content
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Hydrogenated Pyridines (AREA)
Description
(54) СПОСОБ ПОЛУЧЕНИЯ КОРОНАРОРАСШИРЯЮЩЕГО
СРЕДСТВА
1
Изобретение относитс к производству лекарственных препаратов.
Известен способ получени коропарорасшир ющего средства путем добавлени к 1,4-дигидропиридинам восстановительной системы, например Fen (Fem, аскорбиновой кислоты) дегидроаскорбиновой кислоты, и помещени смеси в толстостенные темно-коричневые бутыли .
С целью повышени стабильности целевого продукта и обеспечени его быстрого фармакологического эффекта но предлагаемому способу 4- (2-иитрофенил) -2,6-диметил-3,5-дикарбометокси-1 ,4-дигидропиридина смешивают с полиалкиленгликолем, имеюш.им 2-3 атома углерода в алкиленовом радикале и средним молекул рным весом 200-4000, например полпоксиэтилен 300, низшим спиртом, имеющим 2-8 атомов углерода и 1-3 гидроксильные группы, например пропиленгликоль, п помеП1ают в желатиновые капсулы, содержащие свсюпоглощающее вещество, например двуокись титана и краситель, например желтооранжевый-S .
Пример. Капсулы состо т из желатиновой оболочки, содержащей в готовом виде 54--80% желатина, 10-36% глицерина, 7-
15% воды и 0,5-5,0% средства, делающего их непрозрачными, такие как диокись титана, окись железа, желта окись железа, красна окись железа, коричнева окись железа или карбонат кальци , предпочтительно диокись титана и краситель желтооранжевый-S. Дл получени желатиновой массы дл оболочек капсул сначала перемещивают 40-66% чистого желатппа с 8-36% глицерина (или
сорбита) и 22-34% воды п оставл ют набухать в течение некоторого времени. Затем массу расплавл ют при температуре около 60°С до отсутстви пузырей и гомогенно втирают средство, делающее их непрозрачными,
и краситель желтооранжевый-S, а также еще консервирующие средства (например, сложный эфир параамипобензойной кислоты, сорбннова кислота, бензиловый спирт и т. д.). Препарат дл наполнени капсул получают
путем смешивани 4-(2-нитрофенил)-2,6-диметил-3 ,5-дикарбометокси-1,4 - дигидропиридина с нолиалкпленгликолем, имеющим 2- 3 атома углерода в алкиленовом радикале и средним молекул рным весом 200-4000, например полиоксиэтилен 300, низшим спиртом, имеющим 2-8 атомов углерода и 1-3 гидроксильные группы, например пропиленгликоль,
Примен ют полигликоли, такие как (Hoecnst),
Лутроль 9 (BASF), полидиолы
(Hiils),
/р
карбоваксы- (Union Carbide), а из низших спиртов примен ют глицерин, пропиленгликоль или бутиленгликоль. Вспомогательными средствами препарата могут быть применены вкусовые вещества или эфирные масла, предпочтительно м тное масло, аниловое, тминоfioe , лимонное или эвкалиптовое масло, подслаживающие средства, например сахарин, пикломат , соль аммони глицирезиновой кислоты и т. д.
Предмет изобретени
Способ получени коронарорасшир ющего средства путем добавлени к 4- (2-нитрофенил )-2,6-д-иметил-3,5-дикарбометокси - 1,4 дигидропиридина стабилизирующих веществ, отличающийс тем, что, с целью повышени стабильности целевого продукта и
обеспечени его быстрого фармакологического эффекта, 4- (2 - нитрофенил) -2,6-диметил-3,5дикарбометокси-1 ,4-дигидропиридина смешивают с полиалкиленгликолем, имеющим 2- 3 атома углерода в алкилеповом радикале и
средним молекул рным весом 200-4000, например полиоксиэтилен-300, низшим спиртом, имеющим 2-8 атомов углерода и 1-3 гидроксильные группы, например пропиленгликоль, и помещают в желатиновые капсулы, содержащие светопоглощающее вещество, например двуокись титана и краситель, например желтооранжевый-S.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2142316 | 1971-08-24 | ||
DE19722209526 DE2209526C3 (de) | 1972-02-29 | 1972-02-29 | Coronartherapeutlkum in Form von Gelatine-BeiBkapseln |
Publications (1)
Publication Number | Publication Date |
---|---|
SU432703A3 true SU432703A3 (ru) | 1974-06-15 |
Family
ID=25761638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU1820018A SU432703A3 (ru) | 1971-08-24 | 1972-08-14 |
Country Status (25)
Country | Link |
---|---|
US (1) | US3784684A (ru) |
JP (2) | JPS5434048B2 (ru) |
KR (1) | KR780000433B1 (ru) |
BE (1) | BE787951A (ru) |
BG (1) | BG27728A3 (ru) |
CA (1) | CA981582A (ru) |
CY (1) | CY918A (ru) |
DD (1) | DD99729A5 (ru) |
DK (1) | DK130628B (ru) |
EG (1) | EG10633A (ru) |
ES (1) | ES406047A1 (ru) |
FI (1) | FI53922C (ru) |
FR (1) | FR2150848B1 (ru) |
GB (1) | GB1362627A (ru) |
HK (1) | HK44877A (ru) |
IE (1) | IE36891B1 (ru) |
IL (1) | IL40165A (ru) |
KE (1) | KE2756A (ru) |
LU (1) | LU65929A1 (ru) |
MY (1) | MY7800003A (ru) |
NL (1) | NL176836C (ru) |
NO (1) | NO138167C (ru) |
RO (1) | RO88521B (ru) |
SG (1) | SG34877G (ru) |
SU (1) | SU432703A3 (ru) |
Families Citing this family (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA725808B (en) * | 1971-08-24 | 1973-05-30 | Bayer Ag | A coronary agent in special form and processes for its manufacture |
SU432703A3 (ru) * | 1971-08-24 | 1974-06-15 | Фридрих Боссерт, Вульф Фатер, Курт Бауер | |
GB1481411A (en) * | 1973-07-20 | 1977-07-27 | Scherer Ltd R | Pharmaceutical compositions |
US4198391A (en) * | 1973-07-20 | 1980-04-15 | R. P. Scherer Ltd. | Pharmaceutical compositions |
AT366576B (de) * | 1974-02-22 | 1982-04-26 | Wellcome Found | Verfahren zur herstellung von pharmazeutischen praeparaten |
US4002718A (en) * | 1974-10-16 | 1977-01-11 | Arnar-Stone Laboratories, Inc. | Gelatin-encapsulated digoxin solutions and method of preparing the same |
US4056610A (en) * | 1975-04-09 | 1977-11-01 | Minnesota Mining And Manufacturing Company | Microcapsule insecticide composition |
JPS52151724A (en) * | 1976-06-07 | 1977-12-16 | Takeda Chem Ind Ltd | Hard shell gelatin capsule |
GB1579818A (en) * | 1977-06-07 | 1980-11-26 | Yamanouchi Pharma Co Ltd | Nifedipine-containing solid preparation composition |
JPS5484023A (en) * | 1977-12-19 | 1979-07-04 | Teijin Ltd | Soft capsule containing active vitamin d3, and its preparation |
JPS5522631A (en) * | 1978-08-07 | 1980-02-18 | Ota Seiyaku Kk | Readily absorbable nifedipine preparation |
JPS5522645A (en) * | 1978-08-07 | 1980-02-18 | Fujisawa Pharmaceut Co Ltd | Soft capsule for encapsulation of light-unstable compound |
US5264446A (en) * | 1980-09-09 | 1993-11-23 | Bayer Aktiengesellschaft | Solid medicament formulations containing nifedipine, and processes for their preparation |
US4366145A (en) * | 1981-06-24 | 1982-12-28 | Sandoz, Inc. | Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation |
JPS5939827A (ja) * | 1982-08-27 | 1984-03-05 | Nitto Electric Ind Co Ltd | 医療用外用部材 |
GB8305693D0 (en) * | 1983-03-02 | 1983-04-07 | Scherer Ltd R P | Pharmaceutical compositions |
DE3307353C2 (de) * | 1983-03-02 | 1985-01-31 | R.P. Scherer GmbH, 6930 Eberbach | Polyethylenglykolhaltige Weichgelatinekapsel und Verfahren zu ihrer Herstellung |
DE3307422A1 (de) * | 1983-03-03 | 1984-09-06 | Bayer Ag, 5090 Leverkusen | Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen |
US4832952A (en) * | 1983-07-07 | 1989-05-23 | American Home Products Corporation | Pharmaceutical composition containing a liquid lubricant |
US4777048A (en) * | 1983-07-07 | 1988-10-11 | American Home Products Corporation | Pharmaceutical composition containing a liquid lubricant |
US4620974A (en) * | 1983-07-07 | 1986-11-04 | American Home Products Corporation | Pharmaceutical composition containing a liquid lubricant |
DE3376198D1 (en) * | 1983-11-30 | 1988-05-11 | Siegfried Ag | Therapeutic coronary composition in the form of soft gelatine capsules |
DE3419130A1 (de) * | 1984-05-23 | 1985-11-28 | Bayer Ag, 5090 Leverkusen | Nifedipinkombinationspraeparate und verfahren zu ihrer herstellung |
DE3419129A1 (de) * | 1984-05-23 | 1985-11-28 | Bayer Ag, 5090 Leverkusen | Nifedipinpraeparate und verfahren zu ihrer herstellung |
US5266581A (en) * | 1984-07-04 | 1993-11-30 | Bayer Aktiengesellschaft | Solid composition containing dihydropyridine, PVP and PVPP |
EP0175671A1 (de) * | 1984-08-23 | 1986-03-26 | Kuhlemann & Co. | Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung |
DE3438830A1 (de) * | 1984-10-23 | 1986-04-30 | Rentschler Arzneimittel | Nifedipin enthaltende darreichungsform und verfahren zu ihrer herstellung |
DE3532129A1 (de) * | 1985-09-10 | 1987-03-12 | Bayer Ag | Ss-carotin enthaltende gelatine |
GB8522453D0 (en) * | 1985-09-11 | 1985-10-16 | Lilly Industries Ltd | Chewable capsules |
DE3544692A1 (de) * | 1985-12-18 | 1987-06-19 | Bayer Ag | Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung |
US4689233A (en) * | 1986-01-06 | 1987-08-25 | Siegfried Aktiengesellschaft | Coronary therapeutic agent in the form of soft gelatin capsules |
US4656028A (en) * | 1986-06-24 | 1987-04-07 | Norcliff Thayer Inc. | Encapsulated antacid |
DE3636123A1 (de) * | 1986-10-23 | 1988-05-05 | Rentschler Arzneimittel | Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten |
DE3639418A1 (de) * | 1986-11-18 | 1988-06-09 | Forschungsgesellschaft Rauchen | Nikotinhaltiges mittel |
GB8629761D0 (en) * | 1986-12-12 | 1987-01-21 | Harris Pharma Ltd | Capsules |
ES2040697T3 (es) * | 1986-12-18 | 1993-11-01 | Kurt H. Prof. Dr. Bauer | Concentrado de nifedipina estabilizado frente a la influencia de la luz, y procedimiento para su preparacion. |
DE3714402A1 (de) * | 1987-04-30 | 1988-11-10 | Kali Chemie Pharma Gmbh | Arzneimittelformulierung |
DE3738236A1 (de) * | 1987-11-11 | 1989-05-24 | Euro Celtique Sa | Beisskapsel |
US4954346A (en) * | 1988-06-08 | 1990-09-04 | Ciba-Geigy Corporation | Orally administrable nifedipine solution in a solid light resistant dosage form |
US4935243A (en) * | 1988-12-19 | 1990-06-19 | Pharmacaps, Inc. | Chewable, edible soft gelatin capsule |
CA2056032A1 (en) * | 1990-11-29 | 1992-05-30 | Minoru Aoki | Hard capsule preparation |
US5431916A (en) * | 1993-04-29 | 1995-07-11 | The Procter & Gamble Company | Pharmaceutical compositions and process of manufacture thereof |
US5773025A (en) * | 1993-09-09 | 1998-06-30 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems--amorphous drugs |
US6726930B1 (en) * | 1993-09-09 | 2004-04-27 | Penwest Pharmaceuticals Co. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
US5455046A (en) * | 1993-09-09 | 1995-10-03 | Edward Mendell Co., Inc. | Sustained release heterodisperse hydrogel systems for insoluble drugs |
US5641512A (en) * | 1995-03-29 | 1997-06-24 | The Procter & Gamble Company | Soft gelatin capsule compositions |
AU2190697A (en) * | 1996-04-12 | 1997-11-07 | Flemington Pharmaceutical Corporation | Buccal polar spray or capsule |
AU695734B2 (en) | 1996-07-08 | 1998-08-20 | Penwest Pharmaceuticals Co. | Sustained release matrix for high-dose insoluble drugs |
JP4730985B2 (ja) * | 1997-09-10 | 2011-07-20 | 武田薬品工業株式会社 | 安定化された医薬製剤 |
US20040136913A1 (en) * | 1997-10-01 | 2004-07-15 | Dugger Harry A. | Buccal, polar and non-polar spray containing sumatriptan |
US20030077229A1 (en) * | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs |
US20030095927A1 (en) * | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders |
US20030077227A1 (en) * | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
US7632517B2 (en) * | 1997-10-01 | 2009-12-15 | Novadel Pharma Inc. | Buccal, polar and non-polar spray containing zolpidem |
US20050180923A1 (en) * | 1997-10-01 | 2005-08-18 | Dugger Harry A.Iii | Buccal, polar and non-polar spray containing testosterone |
US20040136915A1 (en) * | 1997-10-01 | 2004-07-15 | Dugger Harry A. | Buccal, polar and non-polar spray containing atropine |
US20050002867A1 (en) * | 1997-10-01 | 2005-01-06 | Novadel Pharma Inc. | Buccal, polar and non-polar sprays containing propofol |
US20050281752A1 (en) * | 1997-10-01 | 2005-12-22 | Dugger Harry A Iii | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
US20040141923A1 (en) * | 1997-10-01 | 2004-07-22 | Dugger Harry A. | Buccal, polar and non-polar spray containing alprazolam |
US20030190286A1 (en) * | 1997-10-01 | 2003-10-09 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma |
US20090162300A1 (en) * | 1997-10-01 | 2009-06-25 | Dugger Iii Harry A | Buccal, polar and non-polar spray containing alprazolam |
US20050163719A1 (en) * | 1997-10-01 | 2005-07-28 | Dugger Harry A.Iii | Buccal, polar and non-polar spray containing diazepam |
US20030077228A1 (en) * | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders |
US20030095926A1 (en) * | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
US20030082107A1 (en) * | 1997-10-01 | 2003-05-01 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
US20040136914A1 (en) | 1997-10-01 | 2004-07-15 | Dugger Harry A. | Buccal, polar and non-polar spray containing ondansetron |
US20030185761A1 (en) * | 1997-10-01 | 2003-10-02 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
EP2042161A1 (en) * | 1997-10-01 | 2009-04-01 | Novadel Pharma Inc. | Propellant-free spray composition comprising anti-emetic agent |
US20050287075A1 (en) * | 1997-10-01 | 2005-12-29 | Dugger Harry A Iii | Buccal, polar and non-polar spray or capsule containing drugs for treating pain |
US20030095925A1 (en) * | 1997-10-01 | 2003-05-22 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders |
US6056977A (en) | 1997-10-15 | 2000-05-02 | Edward Mendell Co., Inc. | Once-a-day controlled release sulfonylurea formulation |
US20030102246A1 (en) * | 1999-03-20 | 2003-06-05 | Lts Lohmann Therapie-Systeme Ag | Method for improving the stability of stored and/or used light-sensitive therapeutic systems or components thereof |
CN1179725C (zh) * | 1999-08-31 | 2004-12-15 | 中外制药株式会社 | 软胶囊剂 |
WO2001022940A1 (en) * | 1999-09-30 | 2001-04-05 | Edward Mendell Co., Inc. | Sustained release matrix systems for highly soluble drugs |
US20030003144A1 (en) * | 2001-05-01 | 2003-01-02 | Keller Brian C. | Sustained release formulations for nifedipine, dextromethorphan, and danazol |
US20030070679A1 (en) * | 2001-06-01 | 2003-04-17 | Boehringer Ingelheim Pharma Kg | Capsules containing inhalable tiotropium |
ES2302926T5 (es) | 2002-04-25 | 2012-08-23 | Banner Pharmacaps, Inc. | Cápsula blanda masticable |
JP5105705B2 (ja) * | 2002-05-09 | 2012-12-26 | 中外製薬株式会社 | 光安定化軟カプセル剤 |
WO2007052592A1 (ja) * | 2005-10-31 | 2007-05-10 | Kowa Co., Ltd. | 光安定性に優れた医薬製剤 |
JP2009534387A (ja) * | 2006-04-19 | 2009-09-24 | ノヴァデル ファーマ インコーポレイテッド | 安定な含水アルコール性経口噴霧調剤物および方法 |
US20080171089A1 (en) * | 2006-12-22 | 2008-07-17 | Blondino Frank E | Stable anti-nausea oral spray formulations and methods |
EP2152247A4 (en) * | 2007-05-10 | 2012-12-26 | Novadel Pharma Inc | COMPOSITIONS AND METHODS ANTI-INSOMNIA |
US7985325B2 (en) * | 2007-10-30 | 2011-07-26 | Novellus Systems, Inc. | Closed contact electroplating cup assembly |
JP2011510005A (ja) * | 2008-01-18 | 2011-03-31 | ダウ グローバル テクノロジーズ インコーポレイティド | メトキシポリエチレングリコールを用いる難溶性活性物質の水溶解度増強方法 |
CN106344533A (zh) * | 2009-01-29 | 2017-01-25 | 大日本住友制药株式会社 | 具有内核的口腔崩解片剂 |
CN102160872A (zh) | 2010-02-23 | 2011-08-24 | 天津天士力制药股份有限公司 | 复方丹参滴丸胶囊 |
TWI571257B (zh) * | 2011-02-23 | 2017-02-21 | Tasly Pharmaceutical Group Co | Capsule preparation |
WO2019219693A1 (en) | 2018-05-14 | 2019-11-21 | Capsugel Belgium Nv | Capsules with opacifier |
WO2019241519A1 (en) | 2018-06-14 | 2019-12-19 | Astrazeneca Uk Limited | Methods for lowering blood pressure with a dihydropyridine-type calcium channel blocker pharmaceutical composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2870061A (en) * | 1956-11-08 | 1959-01-20 | Mead Johnson & Co | Concentrates of dialkyl sulfosuccinates |
US3155587A (en) * | 1963-01-23 | 1964-11-03 | American Cyanamid Co | Stable liquid preparations of 7-chlorotetracycline |
DE1670827C3 (de) * | 1967-03-20 | 1974-10-24 | Bayer Ag, 5090 Leverkusen | 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin |
SU432703A3 (ru) * | 1971-08-24 | 1974-06-15 | Фридрих Боссерт, Вульф Фатер, Курт Бауер |
-
1972
- 1972-08-14 SU SU1820018A patent/SU432703A3/ru active
- 1972-08-19 BG BG021232A patent/BG27728A3/xx unknown
- 1972-08-21 EG EG341/72A patent/EG10633A/xx active
- 1972-08-21 US US00282476A patent/US3784684A/en not_active Expired - Lifetime
- 1972-08-21 IL IL40165A patent/IL40165A/xx unknown
- 1972-08-22 IE IE1151/72A patent/IE36891B1/xx unknown
- 1972-08-22 LU LU65929A patent/LU65929A1/xx unknown
- 1972-08-22 FI FI2317/72A patent/FI53922C/fi active
- 1972-08-22 DD DD165182A patent/DD99729A5/xx unknown
- 1972-08-22 RO RO72017A patent/RO88521B/ro unknown
- 1972-08-22 CA CA149,949A patent/CA981582A/en not_active Expired
- 1972-08-23 ES ES406047A patent/ES406047A1/es not_active Expired
- 1972-08-23 DK DK417572AA patent/DK130628B/da not_active IP Right Cessation
- 1972-08-23 GB GB3922672A patent/GB1362627A/en not_active Expired
- 1972-08-23 NO NO3021/72A patent/NO138167C/no unknown
- 1972-08-23 CY CY918A patent/CY918A/xx unknown
- 1972-08-24 BE BE787951A patent/BE787951A/xx not_active IP Right Cessation
- 1972-08-24 JP JP8414772A patent/JPS5434048B2/ja not_active Expired
- 1972-08-24 FR FR7230198A patent/FR2150848B1/fr not_active Expired
- 1972-08-24 NL NLAANVRAGE7211565,A patent/NL176836C/xx not_active IP Right Cessation
- 1972-08-24 KR KR7201276A patent/KR780000433B1/ko active
-
1977
- 1977-08-16 KE KE2756A patent/KE2756A/xx unknown
- 1977-09-01 HK HK448/77A patent/HK44877A/xx unknown
- 1977-12-31 SG SG348/77A patent/SG34877G/en unknown
-
1978
- 1978-03-16 JP JP2936178A patent/JPS53121921A/ja active Pending
- 1978-12-30 MY MY3/78A patent/MY7800003A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
FI53922C (fi) | 1979-09-07 |
FR2150848A1 (ru) | 1973-04-13 |
CY918A (en) | 1977-12-23 |
NO138167B (no) | 1978-04-10 |
NO138167C (no) | 1978-07-26 |
DK130628B (da) | 1975-03-17 |
RO88521B (ro) | 1987-05-01 |
IL40165A0 (en) | 1972-10-29 |
ES406047A1 (es) | 1981-08-16 |
KR780000433B1 (en) | 1978-10-14 |
RO88521A (ro) | 1987-04-30 |
IE36891L (en) | 1973-02-24 |
MY7800003A (en) | 1978-12-31 |
SG34877G (en) | 1987-04-03 |
BG27728A3 (en) | 1979-12-12 |
GB1362627A (en) | 1974-08-07 |
JPS5434048B2 (ru) | 1979-10-24 |
CA981582A (en) | 1976-01-13 |
DK130628C (ru) | 1975-08-25 |
JPS53121921A (en) | 1978-10-24 |
KE2756A (en) | 1977-10-14 |
EG10633A (en) | 1976-08-31 |
NL176836C (nl) | 1985-06-17 |
HK44877A (en) | 1977-09-09 |
NL7211565A (ru) | 1973-02-27 |
IL40165A (en) | 1975-03-13 |
DD99729A5 (ru) | 1973-08-20 |
JPS4828621A (ru) | 1973-04-16 |
LU65929A1 (ru) | 1973-01-15 |
NL176836B (nl) | 1985-01-16 |
FI53922B (fi) | 1978-05-31 |
FR2150848B1 (ru) | 1976-04-16 |
IE36891B1 (en) | 1977-03-16 |
BE787951A (fr) | 1973-02-26 |
US3784684A (en) | 1974-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SU432703A3 (ru) | ||
SG61583G (en) | Novel derivatives of glycerin,their preparation and pharmaceutical compositions containing them | |
KR850002954A (ko) | 젤라틴 캡슐 | |
GB2075560A (en) | Hydroxyl derivatives of benzaldehyde for colouring keratin fibres | |
SE8402550D0 (sv) | N-substituerade deriavat av moranolin | |
BE847742A (fr) | Nouvelles imidazolidines, procede de preparation et compositions pharmaceutiques | |
GB1144225A (en) | Preparation of medicinal capsule shells from hydroxyalkyl-alkyl cellulose ethers | |
EP0165352A3 (en) | Clear micellized solutions of fat soluble essential nutrients | |
Khanna et al. | Epoxy resin beads as a pharmaceutical dosage form I: Method of preparation | |
BE841794A (fr) | Nouveaux derives n-substitues de la phenyl-piperidine et leurs sels, procede de preparation et compositions pharmaceutiques | |
ATE33348T1 (de) | Coronartherapeutikum in form von weichgelatinekapseln. | |
KR850006138A (ko) | 플라본이 풍부한 카모밀라 추출물의 제조방법 | |
BE848227A (fr) | Nouveaux composes heterocycliques et compositions pharmaceutiques les contenant, | |
PH13924A (en) | Glavulanic acid derivatives,pharmaceutical compositions containing same and method of preparation thereof | |
ES428443A1 (es) | Una dosis unitaria cardiotonica. | |
BE841793A (fr) | Nouveaux derives de la phenyl-piperidine et leurs sels, procede de preparation et compositions pharmaceutiques | |
JPS53139716A (en) | Pharmaceutical preparation of stable prostaglandine | |
BE832121A (fr) | Nouveaux composes anti-arythmiques et compositions pharmaceutiques les contenant | |
CS199202B2 (en) | Method of producing gelatine capsules to be bitten up | |
JPH0669933B2 (ja) | 皮膚化粧料 | |
FR2340724A2 (fr) | Nouveaux diarylacetamides substitues, leurs procedes de preparation et les compositions pharmaceutiques en contenant | |
JPS5495721A (en) | Nifedipine preparation | |
AT366573B (de) | Verfahren zur herstellung einer pharmazeutischen zubereitung | |
KR910004202A (ko) | 동물의 세포보호제 및 그 제조방법 | |
BE843535A (fr) | Nouveaux derive de la desoxystreptamine et ses sels, procede de preparation et compositions pharmaceutiques |